Tiziana Life Sciences (TLSA) announced that its CEO Ivor Elrifi, has purchased 193,848 shares of Tiziana common stock at a price of $1.65 per share in the open market.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences Chairman Increases Stake with Recent Share Purchase
- Tiziana Life Sciences announces purchase of shares by chairman
- Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab
- Tiziana Life doses first patient in Phase 2a trial of intranasal foralumab
- FDA Approves Tiziana Life Sciences’ Phase 2a Trial for MSA